Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Significance: Ketamine is an NMDA receptor (NMDAR) antagonist that elicits rapid antidepressant responses in patients with treatment-resistant depression. However, ketamine can also produce adverse side effects, which raised interest in whether the clinically tolerated NMDAR antagonist memantine can elicit similar fast antidepressant action. Rather surprisingly, clinical data have shown that memantine does not trigger rapid antidepressant effects for reasons that have yet to be elucidated. Here, we reconstitute the ketamine and memantine clinical findings in animal models and, combined with the analysis of synaptic function and subsequent intracellular signaling, demonstrate significant differences between the efficacies of ketamine and memantine on NMDAR-mediated neurotransmission and downstream intracellular signaling. These findings suggest a potential mechanism to explain the earlier clinical observations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This differential effect of ketamine and memantine extended to intracellular signaling coupled to spontaneous NMDA receptors, in that memantine does not inhibit eEF2K nor alter BDNF protein expression in the hippocampus, key determinants of ketamine mediated rapid antidepressant effects (Gideons et al., 2014).”
From BDNF - a key transducer of antidepressant effects (2016) · cites this paper as Gideons et al., 2014
The cited source says what the claim attributes to it.
In the citing paper
“Work done in our laboratory demonstrated that memantine has little effect on the function of NMDA receptors activated by spontaneous neurotransmitter release, in contrast to ketamine.”
From BDNF - a key transducer of antidepressant effects (2016) · cites this paper as Gideons et al., 2014
The cited source says what the claim attributes to it.
In the citing paper
“In contrast, memantine, a non-competitive NMDAR channel blocker, failed to exert antidepressant actions in animal tests 64 and in humans 65–67, and which was suggested to be because memantine does not block NMDAR-mEPSCs under physiological Mg2+ levels 64.”
From Mechanisms of ketamine action as an antidepressant (2018) · cites this paper as [64]
The cited source says what the claim attributes to it.
In the citing paper
“Importantly, ketamine’s inhibition of NMDAR-mEPSCs occurs at physiological levels of Mg2+, an effect that was associated with the rapid antidepressant behavioral actions of ketamine 64.”
From Mechanisms of ketamine action as an antidepressant (2018) · cites this paper as [64]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881 · cited 1×
“The rapid antidepressant effects of ketamine have also been suggested to be mediated by mammalian target of rapamycin (mTOR)-dependent synapse formation, although it remains unclear how blockade of the NMDAR activates mTOR (30).”
BackgroundNMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926 · cited 10×
“In recent work, we demonstrated that the fast-acting antidepressant effect of ketamine requires deactivation of eukaryotic elongation factor 2 kinase (eEF2K) and subsequent desuppression of BDNF protein translation in the hippocampus (8, 9).”
BackgroundMethodResultSelf-citationMaeng, S., Zarate, C. A., Du, J., Schloesser, R. J., McCammon, J., Chen, G., & Manji, H. K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.028 · Cited by 1,103 · cited 1×
“In all experiments, we included a ketamine group as a direct comparison, which has previously been shown to elicit an antidepressant response in mice 30 min after administration without effects on locomotor activity at this time point (8, 9, 14, 15).”
MethodParsons, C. G., Danysz, W., & Quack, G. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00019-2 · Cited by 878 · cited 2×
“Pharmacol Biochem Behav 53(4): 791–797.”
BackgroundExcitatory glycine receptors containing the NR3 family of NMDA receptor subunits
Chatterton, J. E., Awobuluyi, M., Premkumar, L. S., Takahashi, H., Talantova, M., Shin, Y., Cui, J., Tu, S., Sevarino, K. A., Nakanishi, N., et al. (2002) · Nature · doi:10.1038/nature715 · Cited by 694 · cited 1×
“Additionally, it seems unlikely that any differences found between ketamine and memantine would be mediated by GluN3 containing NMDARs, because they do not show significant sensitivity to blockade by Mg or use dependent blockers (23, 24).”
BackgroundSutton, M. A., Ito, H. T., Cressy, P., Kempf, C., Woo, J. C., & Schuman, E. M. (2006) · Cell · doi:10.1016/j.cell.2006.03.040 · Cited by 633 · cited 1×
“Blockade of NMDAR-mEPSCs has been linked to the control of dendritic protein translation by decreasing calcium influx through the NMDAR into the synapse, leading to decreased phosphorylation of eEF2 by eEF2K and desuppression of protein translation (10, 12), thus providing a potential mechanism for A”
BackgroundPrice, R. B., Nock, M. K., Charney, D. S., & Mathew, S. J. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.04.029 · Cited by 600
Voltage dependence of NMDA-activated macroscopic conductances predicted by single-channel kinetics
Jahr, C., & Stevens, C. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-09-03178.1990 · Cited by 564
A Double-Blind, Placebo-Controlled Study of Memantine in the Treatment of Major Depression
Zarate, C. A., Singh, J. B., Quiroz, J. A., De Jesus, G., Denicoff, K. K., Luckenbaugh, D. A., Manji, H. K., & Charney, D. S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.153 · Cited by 387 · cited 1×
“However, in two recent clinical trials, chronic memantine did not elicit an antidepressant response in depressed patients compared with patients given placebo (5, 7).”
ResultA quantitative description of NMDA receptor-channel kinetic behavior
Jahr, C., & Stevens, C. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-06-01830.1990 · Cited by 320
Acute suppression of spontaneous neurotransmission drives synaptic potentiation
Nosyreva, E., Szabla, K., Autry, A. E., Ryazanov, A. G., Monteggia, L. M., & Kavalali, E. T. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.4998-12.2013 · Cited by 283 · cited 9×
“Recent electrophysiological studies have shown that blockade of the NMDAR by Mg is incomplete, even at physiological resting potentials, allowing for a significant amount of current to flow through the NMDAR (9, 18, 25).”
BackgroundMethodResultSelf-citationCollingridge, G. L., Herron, C. E., & Lester, R. A. (1988) · The Journal of Physiology · doi:10.1113/jphysiol.1988.sp017080 · Cited by 275
Sutton, M. A., Taylor, A. M., Ito, H. T., Pham, A., & Schuman, E. M. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.030 · Cited by 274
Mg2+Imparts NMDA Receptor Subtype Selectivity to the Alzheimer's Drug Memantine
Kotermanski, S. E., & Johnson, J. W. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3703-08.2009 · Cited by 271 · cited 2×
“31 μM) (22), which may indicate a higher affinity for the receptor.”
BackgroundRegulation of Dendritic Protein Synthesis by Miniature Synaptic Events
Sutton, M. A., Wall, N. R., Aakalu, G. N., & Schuman, E. M. (2004) · Science · doi:10.1126/science.1096202 · Cited by 263 · cited 1×
“Blockade of NMDAR-mEPSCs has been linked to the control of dendritic protein translation by decreasing calcium influx through the NMDAR into the synapse, leading to decreased phosphorylation of eEF2 by eEF2K and desuppression of protein translation (10, 12), thus providing a potential mechanism for A”
BackgroundSynaptic Mechanisms Underlying Rapid Antidepressant Action of Ketamine
Kavalali, E. T., & Monteggia, L. M. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12040531 · Cited by 258 · cited 3×
“In this study, we found that memantine does not inhibit the phosphorylation of eEF2 or augment subsequent expression of BDNF, which are necessary requirements for ketamine-mediated antidepressant efficacy (8, 9, 13).”
BackgroundResultSelf-citationFrequency‐dependent N‐methyl‐D‐aspartate receptor‐mediated synaptic transmission in rat hippocampus.
Collingridge, G. L., Herron, C. E., & Lester, R. A. (1988) · The Journal of Physiology · doi:10.1113/jphysiol.1988.sp017081 · Cited by 219
The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine
Monteggia, L. M., Gideons, E., & Kavalali, E. T. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.006 · Cited by 198 · cited 1×
“BDNF is a potent activator of mTOR; thus, the blockade of NMDAR-mEPSCs and inactivation of eEF2K, leading to decreased phosphorylation of eEF2 and, ultimately, up-regulation of BDNF protein expression, may well explain the mTOR findings (31).”
Self-citationMantovani, M., Pértile, R., Calixto, J. B., Santos, A. R. S., & Rodrigues, A. L. S. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00306-9 · Cited by 197 · cited 1×
“In all experiments, we included a ketamine group as a direct comparison, which has previously been shown to elicit an antidepressant response in mice 30 min after administration without effects on locomotor activity at this time point (8, 9, 14, 15).”
MethodKashiwagi, K., Masuko, T., Nguyen, C. D., Kuno, T., Tanaka, I., Igarashi, K., & Williams, K. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12116-5 · Cited by 166 · cited 1×
“Previous work has shown that ketamine and memantine block the NMDAR by binding inside of the ion channel in an area overlapping the binding site for Mg, which blocks the channel in a voltage-dependent manner (21).”
BackgroundThe NMDA antagonist memantine blocks the expression and maintenance of morphine dependence
Popik, P., & Skolnick, P. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02163-9 · Cited by 113 · cited 1×
“To examine a range of doses for the effects of this drug in vivo, we injected memantine at 20 mg/kg, a dose reported to have neuroprotective effects in rodents (16); 10 mg/kg, a dose that blocks morphine dependence (17); and 3 mg/kg, a dose that prevents estrogendependent tolerance to morphine.”
BackgroundAn open-label, flexible-dose study of memantine in major depressive disorder
Ferguson, J. M., & Shingleton, R. N. (2007) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3180314ae7 · Cited by 113 · cited 1×
“In a separate open-label trial, depressed patients treated with chronic memantine did show some clinical improvement in ratings of their depression symptoms 1 wk after starting daily dosing and continuing for at least 12 wk; however, this study did not contain a placebo control group (6).”
BackgroundSmothers, C. T., & Woodward, J. J. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.123836 · Cited by 103 · cited 1×
“Additionally, it seems unlikely that any differences found between ketamine and memantine would be mediated by GluN3 containing NMDARs, because they do not show significant sensitivity to blockade by Mg or use dependent blockers (23, 24).”
BackgroundMemantine binding to a superficial site on NMDA receptors contributes to partial trapping
Kotermanski, S. E., Wood, J. T., & Johnson, J. W. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.176297 · Cited by 92 · cited 1×
“The clinical findings demonstrating differences between ketamine and memantine in triggering rapid antidepressant responses are rather surprising, because both drugs are noncompetitive NMDAR antagonists that block the receptor when it is in an open configuration (16, 20).”
BackgroundKetamine as a Fast Acting Antidepressant: Current Knowledge and Open Questions
Salvadore, G., & Singh, J. B. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12103 · Cited by 81 · cited 1×
“However, even the low-dose ketamine used in the depression studies causes psychotomimetic effects in some patients, with the potential for abuse (19).”
BackgroundNMDA Receptor Activation by Spontaneous Glutamatergic Neurotransmission
Espinosa, F., & Kavalali, E. T. (2009) · Journal of Neurophysiology · doi:10.1152/jn.90754.2008 · Cited by 77 · cited 3×
“25 mM Mg, and −67 mV holding potential causes a significant decrease in decay time and charge transfer of mEPSCs (18), suggesting a significant contribution of NMDARs to glutamatergic neurotransmission at rest.”
BackgroundSelf-citationEmnett, C. M., Eisenman, L. N., Taylor, A. M., Izumi, Y., Zorumski, C. F., & Mennerick, S. J. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.089334 · Cited by 69
Lenze, E. J., Skidmore, E. R., Begley, A. E., Newcomer, J. W., Butters, M. A., & Whyte, E. M. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2813 · Cited by 63 · cited 1×
“However, in two recent clinical trials, chronic memantine did not elicit an antidepressant response in depressed patients compared with patients given placebo (5, 7).”
ResultPovysheva, N. V., & Johnson, J. W. (2012) · Journal of Neurophysiology · doi:10.1152/jn.01017.2011 · Cited by 62 · cited 1×
“Recent electrophysiological studies have shown that blockade of the NMDAR by Mg is incomplete, even at physiological resting potentials, allowing for a significant amount of current to flow through the NMDAR (9, 18, 25).”
Background
Research works printed but not linked: 1
- 10.1124/mol.61.3.533 · doi:10.1124/mol.61.3.533 · Paper page
Cited by
Mechanisms of ketamine action as an antidepressant
Zanos, P., & Gould, T. D. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.255 · Cited by 1,127
Ketamine blocks bursting in the lateral habenula to rapidly relieve depression
Yang, Y., Cui, Y., Sang, K., Dong, Y., Ni, Z., Ma, S., & Hu, H. (2018) · Nature · doi:10.1038/nature25509 · Cited by 1,036
BDNF - a key transducer of antidepressant effects
Björkholm, C., & Monteggia, L. M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.034 · Cited by 958
“receptors, in that memantine does not inhibit eEF2K nor alter BDNF protein expression in the hippocampus, key determinants of ketamine mediated rapid antidepressant effects (Gideons et al., 2014).”
BackgroundSelf-citationBDNF signaling in context: From synaptic regulation to psychiatric disorders
Wang, C. S., Kavalali, E. T., & Monteggia, L. M. (2022) · Cell · doi:10.1016/j.cell.2021.12.003 · Cited by 607
Self-citationKetamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression.
Newport, D. J., Carpenter, L. L., McDonald, W. M., Potash, J. B., Tohen, M., Nemeroff, C. B., & The APA Council of Research Task Force on Novel Biomarkers and Treatments (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15040465 · Cited by 598
Metadata
- Authors
- Gideons, E. S., Kavalali, E. T., & Monteggia, L. M.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2014-05-27
- Volume
- 111
- Issue
- 23
- Pages
- 8649-8654
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC4060670
- OpenAlex
- W2033919519
- Cited by
- 232
- References
- 31
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 15 · 2023: 13 · 2022: 14 · 2021: 16 · 2020: 24 · 2019: 20 · 2018: 23 · 2017: 21 · 2016: 29 · 2015: 24 · 2014: 11
- FWCI
- 20.59
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (MH 070727, R01MH066198, MH-066198, R01MH070727)
- National Institute of Neurological Disorders and Stroke (T32NS069562)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- ketamine, memantine, rapid antidepressant response, treatment-resistant depression, NMDA receptor antagonism, miniature excitatory postsynaptic currents, hippocampal neurons, BDNF expression, intracellular signaling, antidepressant mechanism
- MeSH terms
- Animals, Animals, Newborn, Antidepressive Agents, Cells, Cultured, Hippocampus, Humans, Ketamine, Magnesium, Male, Memantine, Mice, Inbred C57BL, Motor Activity, Neurons, Phosphorylation, Time Factors, Blotting, Western, Receptors, N-Methyl-D-Aspartate, Patch-Clamp Techniques, Excitatory Amino Acid Antagonists, Brain-Derived Neurotrophic Factor, Excitatory Postsynaptic Potentials, Peptide Elongation Factor 2, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.